CP and COVID-19: For instance, Duan and colleagues [11] recruited 10 critically ill adults and found that one dose (200 ml) of CP, besides being well tolerated and without side-effects, could significantly elicit the formation of a high amount of neutralizing antibodies, counteracting COVID-19-related viraemia and radiological manifestations in a week, with an improvement of clinical symptoms in 3 days.